S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
NASDAQ:SNDX

Syndax Pharmaceuticals (SNDX) News Headlines

$23.87
+1.17 (+5.15%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$21.95
$24.28
50-Day Range
$15.60
$23.87
52-Week Range
$13.27
$24.28
Volume
960,733 shs
Average Volume
641,285 shs
Market Capitalization
$1.34 billion
P/E Ratio
70.21
Dividend Yield
N/A
Price Target
$30.75
Get Syndax Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.

SNDX Media Mentions By Week

SNDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNDX
News Sentiment

0.82

0.34

Average
Medical
News Sentiment

SNDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNDX Articles
This Week

9

1

SNDX Articles
Average Week



SourceHeadline
MarketBeat logoSyndax Pharmaceuticals (SNDX) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - August 7 at 6:18 AM
uk.finance.yahoo.com logoSyndax Pharmaceuticals, Inc. (SNDX)
uk.finance.yahoo.com - August 5 at 8:52 PM
finance.yahoo.com logoRecent Price Trend in Syndax (SNDX) is Your Friend, Here's Why
finance.yahoo.com - August 4 at 2:47 PM
finance.yahoo.com logoSyndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022
finance.yahoo.com - August 2 at 7:43 AM
finance.yahoo.com logoDoes Syndax (SNDX) Have the Potential to Rally 67% as Wall Street Analysts Expect?
finance.yahoo.com - August 1 at 4:15 PM
MarketBeat logoSyndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 6.1%
americanbankingnews.com - July 31 at 4:26 AM
MarketBeat logoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $30.67 Consensus Target Price from Brokerages
americanbankingnews.com - July 31 at 1:48 AM
MarketBeat logoMichael A. Metzger Sells 31,602 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock
americanbankingnews.com - July 28 at 5:52 AM
MarketBeat logoSyndax Pharmaceuticals (NASDAQ:SNDX) Trading Up 3.7%
americanbankingnews.com - July 24 at 2:32 AM
finance.yahoo.com logoSyndax Pharmaceuticals Stock Sees RS Rating Rise To 92
finance.yahoo.com - June 30 at 3:31 PM
finance.yahoo.com logoFastest-growing public companies: Revenue spikes for Waltham cancer drug firm
finance.yahoo.com - June 17 at 6:04 AM
seekingalpha.com logoKeith Goldan joins Syndax Pharmaceuticals as CFO
seekingalpha.com - June 13 at 12:31 PM
nasdaq.com logoSyndax Pharmaceuticals Appoints Keith Goldan As CFO
nasdaq.com - June 13 at 12:31 PM
nasdaq.com logoBullish Two Hundred Day Moving Average Cross - SNDX
nasdaq.com - June 8 at 4:00 PM
finance.yahoo.com logoSyndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day
finance.yahoo.com - May 11 at 9:15 AM
investing.com logoSyndax Pharmaceuticals Reports In-Line Q1 EPS
investing.com - May 9 at 9:21 PM
seekingalpha.com logoSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:21 PM
seekingalpha.com logoSyndax Pharmaceuticals Q1 2022 Earnings Preview
seekingalpha.com - May 8 at 7:10 PM
finance.yahoo.com logoSyndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022
finance.yahoo.com - May 2 at 8:31 AM
benzinga.com logoSyndax Pharmaceuticals's Return On Capital Employed Overview
benzinga.com - March 7 at 3:04 PM
finance.yahoo.com logoSyndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - March 4 at 7:54 PM
finance.yahoo.com logoSyndax Pharmaceuticals Announces Transition of Michael A. Metzger to Chief Executive Officer; Briggs W. Morrison, M.D., to Assume Role of President, Head of Research & Development
finance.yahoo.com - February 3 at 8:09 PM
finance.yahoo.com logoSyndax Announces Presentation at B. Riley Securities' 2022 Oncology Conference
finance.yahoo.com - January 20 at 10:36 AM
finance.yahoo.com logoSyndax Announces Presentation at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 9:38 AM
nasdaq.com logoEU Grants Orphan Drug Designation To Syndax's SNDX-5613 For Acute Myeloid Leukemia Treatment
nasdaq.com - December 22 at 9:26 AM
marketwatch.com logoSyndax Gets European Orphan Drug Designation for SNDX-5613 Leukemia Treatment
marketwatch.com - December 22 at 9:26 AM
finance.yahoo.com logoSyndax Announces Orphan Drug Designation Granted to SNDX-5613 by European Commission for the Treatment of Acute Myeloid Leukemia
finance.yahoo.com - December 22 at 9:26 AM
finance.yahoo.com logoSyndax Pharmaceuticals Inc (SNDX) President and COO Michael A Metzger Sold $1.7 million of Shares
finance.yahoo.com - December 21 at 1:13 PM
finance.yahoo.com logoHedge Funds Are Crazy About Syndax Pharmaceuticals, Inc. (SNDX)
finance.yahoo.com - December 14 at 8:13 PM
finance.yahoo.com logoSyndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial
finance.yahoo.com - December 14 at 10:08 AM
benzinga.com logoSyndax Pharmaceuticals Announces Additional...
benzinga.com - December 13 at 6:58 PM
finance.yahoo.com logoSyndax Pharmaceuticals Announces Additional Positive Data Demonstrating Continued Robust Clinical Activity with Durable Responses in Phase 1 Portion of AUGMENT-101 Trial of SNDX-5613
finance.yahoo.com - December 13 at 6:58 PM
benzinga.com logoSyndax Pharmaceuticals Announces Updated Positive...
benzinga.com - December 11 at 6:08 PM
seekingalpha.com logoSyndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 16 at 5:35 AM
finance.yahoo.com logoSyndax Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - November 15 at 8:28 PM
benzinga.com logoEarnings Preview For Syndax Pharmaceuticals
benzinga.com - November 12 at 11:20 PM
finance.yahoo.com logoSyndax to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 15, 2021
finance.yahoo.com - November 8 at 8:29 AM
finance.yahoo.com logoSyndax Pharmaceuticals to Present Updated Data from SNDX-5613 and Axatilimab Clinical Programs During Oral Sessions at 63rd ASH Annual Meeting
finance.yahoo.com - November 4 at 10:05 AM
finance.yahoo.com logoShould I Avoid Syndax Pharmaceuticals, Inc. (SNDX)?
finance.yahoo.com - October 25 at 8:57 PM
finance.yahoo.com logoCan Syndax (SNDX) Climb 48% to Reach the Level Wall Street Analysts Expect?
finance.yahoo.com - October 25 at 10:57 AM
finance.yahoo.com logoSyndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate
finance.yahoo.com - September 27 at 1:26 PM
uk.finance.yahoo.com logoSyndax Pharmaceuticals Inc (SNDX) President and COO Michael A Metzger Sold $1.2 million of Shares
uk.finance.yahoo.com - September 16 at 3:26 AM
finance.yahoo.com logoSyndax Appoints Martin H. Huber, M.D., to its Board of Directors
finance.yahoo.com - September 15 at 5:24 PM
benzinga.com logoSyndax Pharmaceuticals's Return On Capital Employed Insights
benzinga.com - September 14 at 4:23 PM
nasdaq.com logoThose who invested in Syndax Pharmaceuticals (NASDAQ:SNDX) three years ago are up 154%
nasdaq.com - September 6 at 3:15 PM
finance.yahoo.com logoIs Syndax Pharmaceuticals (NASDAQ:SNDX) Using Too Much Debt?
finance.yahoo.com - August 23 at 5:26 PM
seekingalpha.com logoSyndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 10 at 7:08 AM
finance.yahoo.com logoSyndax Pharmaceuticals (SNDX) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 9 at 11:29 PM
finance.yahoo.com logoSyndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - August 9 at 6:29 PM
finance.yahoo.com logoSyndax to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021
finance.yahoo.com - August 2 at 9:28 AM
Get Syndax Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:SNDX) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.